These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38546036)

  • 1. A Predictive Network-Based Immune Checkpoint Blockade Immunotherapeutic Signature Optimizing Patient Selection and Treatment Strategies.
    Zhang N; Yang M; Yang JM; Zhang CY; Guo AY
    Small Methods; 2024 Oct; 8(10):e2301685. PubMed ID: 38546036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conserved immuno-collagenic subtypes predict response to immune checkpoint blockade.
    Mei J; Cai Y; Xu R; Li Q; Chu J; Luo Z; Sun Y; Shi Y; Xu J; Li D; Liang S; Jiang Y; Liu J; Qian Z; Zhou J; Wan M; Yang Y; Zhu Y; Zhang Y; Yin Y
    Cancer Commun (Lond); 2024 May; 44(5):554-575. PubMed ID: 38507505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade.
    Choi Y; Seok SH; Yoon HY; Ryu JH; Kwon IC
    Adv Drug Deliv Rev; 2024 Jun; 209():115306. PubMed ID: 38626859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A computational pipeline for identifying gene targets and signalling pathways in cancer cells to improve lymphocyte infiltration and immune checkpoint therapy efficacy.
    Nasr S; Li L; Asad M; Moridi M; Wang M; Zemp FJ; Mahoney DJ; Wang E
    EBioMedicine; 2024 Jun; 104():105167. PubMed ID: 38805852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenic cell death signatures from on-treatment tumor specimens predict immune checkpoint therapy response in metastatic melanoma.
    Zeng H; Jiang Q; Zhang R; Zhuang Z; Wu J; Li Y; Fang Y
    Sci Rep; 2024 Oct; 14(1):22872. PubMed ID: 39358546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Combination of Biomarkers Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer.
    Jiang Z; Zhou Y; Huang J
    Front Immunol; 2021; 12():813331. PubMed ID: 35003141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal tracing reveals diverse patterns of response to immune checkpoint blockade.
    Gu SS; Wang X; Hu X; Jiang P; Li Z; Traugh N; Bu X; Tang Q; Wang C; Zeng Z; Fu J; Meyer C; Zhang Y; Cejas P; Lim K; Wang J; Zhang W; Tokheim C; Sahu AD; Xing X; Kroger B; Ouyang Z; Long H; Freeman GJ; Brown M; Liu XS
    Genome Biol; 2020 Oct; 21(1):263. PubMed ID: 33059736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE).
    Swami N; Hwang WL; Guo JA; Hoffman H; Abramowitz MC; Elbakouny Z; Beltran H; Chipidza F; Choueiri T; Pra AD; Huang F; Kaochar S; Kantoff P; Kim DW; Kishan AU; Kobetz E; Marinac C; Mucci LA; Muralidhar V; Pollack A; Sanford NN; Schaeffer EM; Spratt DE; Zhao SG; Rebbeck TR; Nguyen PL; Feng FY; Mahal BA; Alshalalfa M
    Cancer Genet; 2021 Nov; 258-259():61-68. PubMed ID: 34551377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational Biology Predicts the Efficacy of Tumor Immune Checkpoint Blockade.
    Kang W; Tong Y; Zhang W; Jian M; Zhang A; Ren G; Fan H; Yang J
    Biomed Res Int; 2022; 2022():6087751. PubMed ID: 36212709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast Cancer.
    Isaacs J; Anders C; McArthur H; Force J
    Curr Treat Options Oncol; 2021 Mar; 22(5):38. PubMed ID: 33743085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating angiogenesis signature and tumor mutation burden for improved patient stratification in immune checkpoint blockade therapy for muscle-invasive bladder cancer.
    Shao F; Jin K; Li B; Liu Z; Zeng H; Wang Y; Zhu Y; Xu L; Xu J; Wang Z; Chang Y; Zhang W
    Urol Oncol; 2023 Oct; 41(10):433.e9-433.e18. PubMed ID: 37625906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards In Silico Prediction of the Immune-Checkpoint Blockade Response.
    Chen K; Ye H; Lu XJ; Sun B; Liu Q
    Trends Pharmacol Sci; 2017 Dec; 38(12):1041-1051. PubMed ID: 29089139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of immune checkpoint and cytokine signatures associated with the response to immune checkpoint blockade in gastrointestinal cancers.
    Zhao C; Wu L; Liang D; Chen H; Ji S; Zhang G; Yang K; Hu Y; Mao B; Liu T; Yu Y; Zhang H; Xu J
    Cancer Immunol Immunother; 2021 Sep; 70(9):2669-2679. PubMed ID: 33624146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene signatures of tumor inflammation and epithelial-to-mesenchymal transition (EMT) predict responses to immune checkpoint blockade in lung cancer with high accuracy.
    Thompson JC; Hwang WT; Davis C; Deshpande C; Jeffries S; Rajpurohit Y; Krishna V; Smirnov D; Verona R; Lorenzi MV; Langer CJ; Albelda SM
    Lung Cancer; 2020 Jan; 139():1-8. PubMed ID: 31683225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic model incorporating immune checkpoint genes to predict the immunotherapy efficacy for lung adenocarcinoma: a cohort study integrating machine learning algorithms.
    Yang XL; Zeng Z; Wang C; Wang GY; Zhang FQ
    Immunol Res; 2024 Aug; 72(4):851-863. PubMed ID: 38755433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting prognosis and clinical efficacy of immune checkpoint blockade therapy
    Fan B; Zheng X; Wang Y; Hu X
    Pathol Oncol Res; 2023; 29():1611117. PubMed ID: 37082269
    [No Abstract]   [Full Text] [Related]  

  • 17. TUBA1C orchestrates the immunosuppressive tumor microenvironment and resistance to immune checkpoint blockade in clear cell renal cell carcinoma.
    Li J; Chen M; Tong M; Cao Q
    Front Immunol; 2024; 15():1457691. PubMed ID: 39301023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8
    Chen X; Xu R; He D; Zhang Y; Chen H; Zhu Y; Cheng Y; Liu R; Zhu R; Gong L; Xiao M; Wang Z; Deng L; Cao K
    Oncogene; 2021 Oct; 40(43):6223-6234. PubMed ID: 34552192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptome Deconvolution Reveals Absence of Cancer Cell Expression Signature in Immune Checkpoint Blockade Response.
    Guo YA; Kulshrestha T; Chang MM; Kassam I; Revkov E; Rizzetto S; Tan AC; Tan DSW; Tan IB; Skanderup AJ
    Cancer Res Commun; 2024 Jun; 4(6):1581-1596. PubMed ID: 38722600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conserved angio-immune subtypes of the tumor microenvironment predict response to immune checkpoint blockade therapy.
    Subramanian M; Kabir AU; Barisas D; Krchma K; Choi K
    Cell Rep Med; 2023 Jan; 4(1):100896. PubMed ID: 36630952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.